These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 3044673

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Nicardipine in the treatment of Raynaud's phenomenon. Dissociation of platelet activation from vasospasm.
    Wigley FM, Wise RA, Malamet R, Scott TE.
    Arthritis Rheum; 1987 Mar; 30(3):281-6. PubMed ID: 2952125
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Double-blind trial of CL115,347, a transdermally absorbed prostaglandin E2 analogue, in treatment of Raynaud's phenomenon.
    Belch JJ, Madhok R, Shaw B, Leiberman P, Sturrock RD, Forbes CD.
    Lancet; 1985 May 25; 1(8439):1180-3. PubMed ID: 2860386
    [Abstract] [Full Text] [Related]

  • 6. A double blind trial of UK-38,485, an orally active thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome.
    Rustin MH, Grimes SM, Kovacs IB, Cooke ED, Bowcock SA, Sowemimo-Coker SO, Turner P, Kirby JD.
    Eur J Clin Pharmacol; 1984 May 25; 27(1):61-5. PubMed ID: 6386490
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
    Lukác J, Rovenský J, Tauchmannová H, Zitnan D.
    Drugs Exp Clin Res; 1985 May 25; 11(9):659-63. PubMed ID: 3916837
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A randomized double blind cross-over trial of nifedipine in the treatment of primary Raynaud's phenomenon.
    Corbin DO, Wood DA, Macintyre CC, Housley E.
    Eur Heart J; 1986 Feb 25; 7(2):165-70. PubMed ID: 3516704
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of long-term ketanserin treatment on 5-HT levels, platelet aggregation and peripheral circulation in patients with Raynaud's phenomenon. A double-blind, placebo-controlled cross-over study.
    Arneklo-Nobin B, Elmér O, Akesson A.
    Int Angiol; 1988 Feb 25; 7(1):19-25. PubMed ID: 3290356
    [Abstract] [Full Text] [Related]

  • 20. Role of digital artery adrenoceptors in Raynaud's disease.
    Cooke JP, Creager SJ, Scales KM, Ren C, Tsapatsaris NP, Beetham WP, Creager MA.
    Vasc Med; 1997 Feb 25; 2(1):1-7. PubMed ID: 9546943
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.